Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mouse response to influenza immunosomes.

A Boudreault, L Thibodeau

    Vaccine
    |September 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Immunosomes, a novel influenza vaccine, generated antibody responses comparable to whole virus vaccines in mice. These immunosomes demonstrated significant protection against influenza variants, highlighting their potential as effective influenza immunizations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: a prospective randomized double-blind sham-controlled multi-center study.

    European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2018
    Same author

    Molecular characterization, enzymatic analysis, and purification of murine proprotein convertase-1/3 (PC1/PC3) secreted from recombinant baculovirus-infected insect cells.

    Protein expression and purification·1999
    Same author

    Proprotein convertase PC1/3-related peptides are potent slow tight-binding inhibitors of murine PC1/3 and Hfurin.

    The Journal of biological chemistry·1998
    Same author

    Clonal deletion of some V beta+ T cells in peripheral lymphocytes from C57BL/6 mice infected with MHV3.

    Advances in experimental medicine and biology·1998
    Same author

    In vitro cleavage of internally quenched fluorogenic human proparathyroid hormone and proparathyroid-related peptide substrates by furin. Generation of a potent inhibitor.

    The Journal of biological chemistry·1998
    Same author

    Prodynorphin processing by proprotein convertase 2. Cleavage at single basic residues and enhanced processing in the presence of carboxypeptidase activity.

    The Journal of biological chemistry·1998

    Area of Science:

    • Virology
    • Immunology
    • Vaccine Development

    Background:

    • Influenza virus poses a significant global health threat, necessitating continuous vaccine development.
    • Current influenza vaccines include whole virus, subunit, and attenuated preparations, each with varying efficacy.
    • Novel vaccine platforms are being explored to improve immunogenicity and protection against evolving influenza strains.

    Purpose of the Study:

    • To evaluate the immunogenicity and protective efficacy of immunosomes as a potential influenza vaccine candidate.
    • To compare the antibody responses and survival rates induced by immunosomes against traditional influenza vaccines.

    Main Methods:

    • Immunosomes were created by anchoring influenza virus surface glycoproteins onto liposomes.
    • Serum antibody responses were measured using the haemagglutination-inhibition assay.

    Related Experiment Videos

  • Mice were immunized with different vaccine types (attenuated, inactivated, subunit, immunosome) and challenged with influenza virus variants to assess survival rates.

    • Main Results:

    • Immunosomes elicited serum antibody responses comparable to whole virus vaccines and superior to subunit vaccines.
    • All tested vaccine preparations conferred similar survival rates against influenza variants prevalent between 1968 and 1977.
    • The attenuated vaccine demonstrated significantly higher protection against the 1979 influenza variant compared to other preparations.

    Conclusions:

    • Immunosomes represent a promising influenza vaccine platform, demonstrating robust immunogenicity in mice.
    • While immunosomes show comparable efficacy to existing vaccines, further research is needed to optimize their protective capacity against emerging variants.
    • Attenuated vaccines may offer enhanced protection against specific, drifted influenza strains.